Alan E. Rothman

• Lead national counsel overseeing settlement and remaining pharmaceutical product liability actions in federal and state court following termination of MDL proceeding.
• Co-lead national settlement counsel for medical device actions in MDL and state court proceedings.
• Representing major pharmaceutical and consumer product companies in MDL and other coordinated proceedings, including proceedings and practice before the Judicial Panel on Multidistrict Litigation, successfully supporting and opposing creation of MDL proceedings.
• Counseling major pharmaceutical companies on issues relating to removal of actions to federal court, corporate structure, personal jurisdiction, Medicare reporting and legal ethics.
• In decision of first impression nationally, successfully orally argued in MDL proceeding deferral of remand issues pending discovery to support fraudulent joinder of in-state defendant.
• In decision of first impression in New York State court, successfully briefed, and secured dismissal of pharmaceutical product claims relating to, liability of clinical trial sponsors and under New York General Business Law Section 349 and 350.
• In coordinated state court proceeding, successfully orally argued in favor coordination of discovery with MDL proceeding.

The above matters were handled prior to joining Sidley.

Alan previously served for six years as a member of the Product Liability Committee of the Association of the Bar of the City of New York and as Chairman of its Subcommittee on New York Coordinated Proceedings. He has also served as a member of the City Bar Association’s Professional & Judicial Ethics Committee. Additionally, Alan has served as an officer and director of various national and local not-for-profit organizations.